Wongvibulsin S, Pahalyants V, Kalinich M, Murphy W, et al. Epidemiology and risk factors for the development of cutaneous toxicities in patients treated with immune-checkpoint inhibitors: A United States population-level analysis. J Am Acad Dermatol 2022;86:563-572.
PMID: 33819538